logo
  • Company
    • About
    • Careers
    • News
    • Honors & Awards
  • Solutions
    • The Galen™ Platform
      • First Read
      • Second Read
    • Ibex Precision Medicine
  • Technology
  • Media
    • Blog
    • Media Library
  • Early Adopter Program
  • Contact Us
logologo
  • Company
    • About
    • Careers
    • News
    • Honors & Awards
  • Solutions
    • The Galen™ Platform
      • First Read
      • Second Read
    • Ibex Precision Medicine
  • Technology
  • Media
    • Blog
    • Media Library
  • Early Adopter Program
  • Contact Us
  • Company
    • About
    • Careers
    • News
    • Honors & Awards
  • Solutions
    • The Galen™ Platform
      • First Read
      • Second Read
    • Ibex Precision Medicine
  • Technology
  • Media
    • Blog
    • Media Library
  • Early Adopter Program
  • Contact Us

Webinar: Is AI clinically useful for cancer diagnosis?

Results from a blinded validation study of an AI-based algorithm on prostate biopsies

banner
  • Home
  • Is AI clinically useful

About this webinar:

This webinar presents the results of a blinded clinical validation study of Ibex’s AI algorithm, performed on an external dataset of prostate biopsies analyzed by independent pathologists at the University of Pittsburgh Medical Center (UPMC).

Pathologists are challenged to provide accurate and timely cancer diagnosis as the number of tests increases year-over-year. Ibex uses artificial intelligence (AI) to develop clinical-grade solutions that extend beyond cancer detection and support pathologists in all clinically significant features, including cancer proportion and perineural invasion, helping them meet reporting needs.

©2020 Ibex Medical Analytics Ltd.All rights reserved.

  • Privacy Policy
  • Terms of Use
  • Contact Us
  • Join Us

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OKPrivacy policy